S&P 500   2,998.89 (+0.42%)
DOW   26,759.57 (-0.04%)
QQQ   192.80 (+0.58%)
AAPL   239.79 (+1.43%)
FB   188.08 (+1.20%)
MSFT   137.84 (+0.31%)
GOOGL   1,245.25 (+0.07%)
AMZN   1,769.62 (+0.69%)
NVDA   194.53 (+2.12%)
MU   44.65 (+2.71%)
BABA   171.48 (+1.39%)
GE   8.88 (-0.89%)
TSLA   254.66 (-0.89%)
AMD   31.87 (+2.91%)
T   38.50 (+0.05%)
ACB   3.54 (-3.80%)
PRI   125.51 (+1.60%)
NFLX   274.64 (-0.24%)
DIS   131.23 (+0.26%)
S&P 500   2,998.89 (+0.42%)
DOW   26,759.57 (-0.04%)
QQQ   192.80 (+0.58%)
AAPL   239.79 (+1.43%)
FB   188.08 (+1.20%)
MSFT   137.84 (+0.31%)
GOOGL   1,245.25 (+0.07%)
AMZN   1,769.62 (+0.69%)
NVDA   194.53 (+2.12%)
MU   44.65 (+2.71%)
BABA   171.48 (+1.39%)
GE   8.88 (-0.89%)
TSLA   254.66 (-0.89%)
AMD   31.87 (+2.91%)
T   38.50 (+0.05%)
ACB   3.54 (-3.80%)
PRI   125.51 (+1.60%)
NFLX   274.64 (-0.24%)
DIS   131.23 (+0.26%)
Log in

Hikma Pharmaceuticals Price Target & Analyst Ratings (LON:HIK)

GBX 1,970
-23.00 (-1.15 %)
(As of 10/21/2019 10:55 AM ET)
Today's Range
1,957
Now: GBX 1,970
1,993
50-Day Range
1,911
MA: GBX 2,047.57
2,200
52-Week Range
1,491.50
Now: GBX 1,970
2,212
Volume256,356 shs
Average Volume822,138 shs
Market Capitalization£4.77 billion
P/E Ratio13.24
Dividend Yield1.37%
BetaN/A

Analyst Ratings

Hikma Pharmaceuticals (LON:HIK) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
7 Wall Street analysts have issued ratings and price targets for Hikma Pharmaceuticals in the last 12 months. Their average twelve-month price target is GBX 1,848.57The high price target for HIK is GBX 2,250 and the low price target for HIK is GBX 1,350. There are currently 1 sell rating, 4 hold ratings and 2 buy ratings for the stock, resulting in a consensus rating of "Hold."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldHoldHold
Consensus Rating Score: 2.142.142.142.14
Ratings Breakdown: 1 Sell Rating(s)
4 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
4 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
4 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
4 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: GBX 1,848.57GBX 1,848.57GBX 1,808.57GBX 1,808.57

Hikma Pharmaceuticals (LON:HIK) Consensus Price Target History

Hikma Pharmaceuticals (LON:HIK) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetDetails
9/2/2019Peel HuntReiterated RatingHold
8/20/2019BarclaysBoost Price TargetEqual weightGBX 1,800 ➝ GBX 1,900
6/18/2019JPMorgan Chase & Co.Reiterated RatingNeutralGBX 1,700
3/19/2019CitigroupUpgradeBuy
3/19/2019Jefferies Financial GroupLower Price TargetBuyGBX 2,000 ➝ GBX 1,960
3/14/2019HSBCBoost Price TargetReduceGBX 1,225 ➝ GBX 1,350
3/13/2019Numis SecuritiesReiterated RatingHoldGBX 1,730
3/15/2018Morgan StanleyBoost Price TargetEqual weightGBX 1,000 ➝ GBX 1,050
11/9/2017Stifel NicolausLower Price TargetHoldGBX 1,320 ➝ GBX 1,000
(Data available from 10/21/2017 forward)
This page was last updated on 10/21/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel